Key points are not available for this paper at this time.
as the most promising molecules to be evaluated as IL-1β and NF-κB inhibitors.
Zazeri et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: